123 related articles for article (PubMed ID: 3303905)
1. A randomized clinical trial of combination chemotherapy in advanced colorectal cancer.
O'Connell MJ; Schutt AJ; Moertel CG; Rubin J; Hahn RG; Scott M
Am J Clin Oncol; 1987 Aug; 10(4):320-4. PubMed ID: 3303905
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
Vogl SE; Qazi R; Berenzweig M
Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy of advanced colorectal cancer with triazinate and ICRF-159 after failure of 5-Fluorouracil.
Vogl SE; Lanham R; Kaplan BH
Oncology; 1980; 37(5):314-5. PubMed ID: 7003455
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Engstrom PF; MacIntyre JM; Mittelman A; Klaassen DJ
Am J Clin Oncol; 1984 Aug; 7(4):313-8. PubMed ID: 6377866
[TBL] [Abstract][Full Text] [Related]
7. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association.
Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ
J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
[No Abstract] [Full Text] [Related]
10. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of methyl-CCNU, vincristine, 5-fluorouracil, and streptozotocin in advanced colorectal cancer. By the Gastrointestinal Tumor Study Group.
J Clin Oncol; 1984 Jul; 2(7):770-3. PubMed ID: 6234380
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
[TBL] [Abstract][Full Text] [Related]
13. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
[TBL] [Abstract][Full Text] [Related]
14. A controlled prospective trial of adjuvant razoxane in resectable colorectal cancer.
Gilbert JM; Cassell PC; Ellis H; Wastell C; Hellmann K; Evans MG; Stoodley BJ
Recent Results Cancer Res; 1981; 79():48-58. PubMed ID: 7029684
[TBL] [Abstract][Full Text] [Related]
15. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
Togni P; Sessa C; Varini M; Cavalli F
Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy with 5-fluorouracil, CCNU, and vincristine in metastatic colorectal carcinoma.
Xavier AM; Kasimis BS; Wu SY; Kaneshiro CA
Am J Clin Oncol; 1984 Oct; 7(5):513-5. PubMed ID: 6391144
[TBL] [Abstract][Full Text] [Related]
17. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
Greco FA; Richardson RL; Shulman SF; Oldham RK
Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
[No Abstract] [Full Text] [Related]
18. Randomized trial of oral adjuvant razoxane (ICRF 159) in resectable colorectal cancer: five-year follow-up.
Gilbert JM; Hellmann K; Evans M; Cassell PG; Taylor RH; Stoodley B; Ellis H; Wastell C
Br J Surg; 1986 Jun; 73(6):446-50. PubMed ID: 3521784
[TBL] [Abstract][Full Text] [Related]
19. Eastern Cooperative Oncology Group phase II studies in advanced measurable colorectal cancer. I. Razoxane, Yoshi-864, piperazinedione, and lomustine.
Douglass HO; MacIntyre JM; Kaufman J; Von Hoff D; Engstrom PF; Klaassen D
Cancer Treat Rep; 1985 May; 69(5):543-5. PubMed ID: 2988774
[TBL] [Abstract][Full Text] [Related]
20. Treatment of advanced colorectal carcinoma with actinomycin D, vincristine, methyl-CCNU, and methotrexate.
Craig JB; Jackson DV; Richards FR; Muss HB; White DR; Cooper MR; Stuart JJ; Spurr CL
Am J Clin Oncol; 1987 Feb; 10(1):44-6. PubMed ID: 3825991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
